XTX Topco’s Bristol-Myers Squibb BMY Stock Holding History

XTX Topco’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$542K	Buy	8,939 +5,077	+131%	+$296K	0.01%	1982
2025 Q4	$208K	Sell	3,862 -173,447	-98%	-$8.34M	0.01%	2370
2025 Q3	$8M	Buy	177,309 +154,076	+663%	+$7.2M	0.41%	7
2025 Q2	$1.08M	Buy	+23,233	New	+$1.14M	0.04%	620
2024 Q3	–	Sell	-91,465	Closed	-$3.8M	–	2110
2024 Q2	$3.8M	Buy	91,465 +73,183	+400%	+$3.27M	0.33%	22
2024 Q1	$991K	Buy	18,282 +11,602	+174%	+$591K	0.13%	163
2023 Q4	$343K	Buy	+6,680	New	+$351K	0.08%	518
2023 Q3	–	Sell	-13,929	Closed	-$891K	–	1578
2023 Q2	$891K	Buy	+13,929	New	+$934K	0.16%	119
2023 Q1	–	Sell	-23,730	Closed	-$1.71M	–	1286
2022 Q4	$1.71M	Buy	+23,730	New	+$1.79M	0.36%	17
2022 Q1	–	Sell	-4,856	Closed	-$303K	–	686
2021 Q4	$303K	Sell	4,856 -7,252	-60%	-$425K	0.17%	193
2021 Q3	$716K	Buy	12,108 +6,260	+107%	+$412K	0.24%	97
2021 Q2	$391K	Sell	5,848 -296	-5%	-$19.3K	0.13%	262
2021 Q1	$388K	Buy	+6,144	New	+$382K	0.19%	179

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

XTX Topco's BMY Position: Q1 2026 in Review

XTX Topco increased its Bristol-Myers Squibb (BMY) stake by 131% in Q1 2026, buying an estimated $296K and bringing the position to 8,939 shares worth $542K. The position accounts for 0.01% of the portfolio, ranked #1982.

XTX Topco first reported a position in BMY in Q1 2021 and has held it in 13 quarters since. The position peaked at $8M in Q3 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

XTX Topco held 8,939 shares of Bristol-Myers Squibb worth $542K as of Q1 2026.
XTX Topco bought 5,077 Bristol-Myers Squibb shares in Q1 2026, an estimated $296K.
Bristol-Myers Squibb made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1982 holding.
XTX Topco first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 13 quarters since.
XTX Topco's Bristol-Myers Squibb position peaked at $8M in Q3 2025.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.